Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04166877 · ClinicalTrials.gov registry record · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
A Phase 4 study of Trauma and Acute Pain, sponsored by University of California, Davis.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 156
- Enrollment target
- 1
- Study location
NCT04166877: Recruiting Phase 4 study of Trauma and Acute Pain, sponsored by University of California, Davis.
NCT04166877 is a Phase 4 study of Trauma and Acute Pain that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 156 participants, below the 305-participant average among 56 other Trauma trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04166877, a Phase 4 study of Trauma and Acute Pain, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 156 participants
- Enrollment target
- 1
- Study location
Study Summary
Magnesium is a naturally occurring mineral that is important for your body and brain. Magnesium sulfate (study drug) is a medication containing magnesium that is commonly used to improve low blood levels of magnesium. Magnesium sulfate has also proven to be successful in managing pain before and after surgery. However, this drug has primarily been used for pain control in patients undergoing surgery. Patients in the ICU with injuries also need good pain control. Using magnesium may assist in decreasing narcotic (pain reliever) requirements and provide another non-narcotic drug for pain control. The purpose of this study is to test the effectiveness of continuous, intravenous (into or within a vein using a needle) administration of magnesium sulfate for pain control in trauma patients admitted to the adult Intensive Care Unit. This will be compared to intravenous normal saline (salt solution).
Primary Outcome
oral morphine equivalents, OME
Conditions Studied
Interventions
- DRUG Magnesium Sulfate in Parenteral Dosage Form
- DRUG Normal saline placebo
Study Locations (1)
California
- UC Davis Health - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2019-12-07 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 4 |
What NCT04166877 shows while recruiting
NCT04166877 is an interventional study that assigns participants to a tested intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap, below the 305-participant average among 56 other Trauma trials with a reported enrollment target (49% lower).
The record links to 2 conditions, with Trauma appearing as the primary indexed condition, and to 2 interventions - of which Magnesium Sulfate in Parenteral Dosage Form is the first listed.
NCT04166877 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04166877 about?
NCT04166877 is a clinical study titled "Magnesium Infusion for Pain Management in Critically Ill Trauma Patients". Magnesium is a naturally occurring mineral that is important for your body and brain. Magnesium sulfate (study drug) is a medication containing magnesium that is commonly used to improve low blood levels of magnesium. Magnesium sulfate has also proven to be successful in managing pain before and aft...
What is the current status of trial NCT04166877?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 156 participants. The study started on 2019-12-07. Estimated completion is 2026-12-31.
What conditions does trial NCT04166877 study?
This clinical trial studies the following conditions: Trauma, Acute Pain.
What interventions are being tested in trial NCT04166877?
The interventions under investigation include: Magnesium Sulfate in Parenteral Dosage Form (DRUG), Normal saline placebo (DRUG).
Who is sponsoring clinical trial NCT04166877?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04166877 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trauma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04166877's enrollment target sits among peer trials
156 25th of 56 higher than 31 of 56 other Trauma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Trauma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
RECRUITING · Phase 4
-
Nonopioid Pain Control Regimen After Open Reduction and Internal Fixation of Traumatic Fractures
RECRUITING · Phase 4
-
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
RECRUITING · Phase 2
-
Testing FIRST in Youth Outpatient Psychotherapy
RECRUITING · NA
-
PRESERVE & CONNECT: Impact Study of the BPC
RECRUITING · NA
-
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT05173714 · 156 participants · Phase 2
Sit Less, Interact and Move More (SLIMM) 2 Study
- NCT05416307 · 156 participants · Phase 2
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI